Literature DB >> 2022171

Cyclosporine and liver regeneration studied by in vivo 31P nuclear magnetic resonance spectroscopy.

L Rossaro1, V Mazzaferro, C L Scotti-Foglieni, K A Porter, D S Williams, E Simplaceanu, V Simplaceanu, A Francavilla, T E Starzl, C Ho.   

Abstract

The changes in fructose-1-phosphate (F-1-P), intracellular pH, and ATP content of the liver after a fructose challenge were investigated noninvasively in vivo using phosphorus-31 nuclear magnetic resonance spectroscopy of dog liver four days after a portacaval shunt (PCS) with or without portal venous infusion of cyclosporin (CsA). The F-1-P metabolism was slower in PCS dogs (N = 2) as compared to either the normal (N = 2) or PCS + CsA-treated dogs (N = 3) (P less than 0.05). The intracellular pH temporarily decreased from 7.3 +/- 0.05 to 7.0 +/- 0.05 during the fructose challenge. The regenerative indexes were increased in the PCS + CsA group (P less than 0.01). These data obtained in vivo using 31P-NMR spectroscopy in the liver following a portacaval shunt, suggest that: (1) the energy status of the liver and the metabolic response to fructose are reduced in PCS compared to normal animals and (2) CsA treatment enhances the regenerative response of the liver and prevents the reduction in hepatic function associated with portacaval shunting.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022171     DOI: 10.1007/bf01297039

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION.

Authors:  Leonard Makowka; Gregory Svanas; Carlos Esquivel; Raman Venkataramanan; Satoru Todo; Shunzaburo Iwatsuki; David Van Thiel; Thomas E Starzl
Journal:  Surg Forum       Date:  1986

2.  Hepatocellular uptake of cyclosporin A by simple diffusion.

Authors:  K Ziegler; G Polzin; M Frimmer
Journal:  Biochim Biophys Acta       Date:  1988-02-08

3.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  Hyperbilirubinaemia and cyclosporin A levels in renal transplant patients.

Authors:  R Loertscher; M Wenk; F Harder; F Brunner; F Follath; G Thiel
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

5.  Hyperbilirubinaemia and cyclosporin A levels.

Authors:  A Laupacis; P A Keown; R A Ulan; N R Sinclair; C R Stiller
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

Review 6.  Application of nuclear magnetic resonance to the study of liver physiology and disease.

Authors:  S M Cohen
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

7.  Cyclosporin A hepatotoxicity in 66 renal allograft recipients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

8.  Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.

Authors:  A W Thomson; P H Whiting; J T Blair; R J Davidson; J G Simpson
Journal:  Transplantation       Date:  1981-10       Impact factor: 4.939

9.  The Eck fistula in animals and humans.

Authors:  T E Starzl; K A Porter; A Francavilla
Journal:  Curr Probl Surg       Date:  1983-11       Impact factor: 1.909

10.  Influence of cyclosporin A treatment on intracellular membranes of hepatocytes.

Authors:  L Bäckman; E L Appelkvist; U Brunk; G Dallner
Journal:  Exp Mol Pathol       Date:  1986-08       Impact factor: 3.362

View more
  1 in total

Review 1.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.